Pharmacists are urging Britain to consider stockpiling medications due to concerns over the impact of Iran’s blockade on the Strait of Hormuz. The Independent Pharmacies Association, representing 5,000 pharmacies in England and Wales, has raised alarm about potential shortages of common drugs like aspirin, paracetamol, ibuprofen, and antibiotics. These medications heavily rely on petroleum-based ingredients and raw materials from the Middle East, making them vulnerable to disruptions in the supply chain.
Dr. Leyla Hannbeck, the association’s chief executive, highlighted the existing shortage of painkillers such as co-codamol and opioids, attributing it to the fragile global supply chains. The tensions surrounding the vital shipping route of the Strait of Hormuz have sparked concerns about increased crude oil prices and disruptions to international trade, impacting the availability of essential medicines.
The supply chain disruptions caused by the situation could affect the production of crucial medications like blood pressure drugs and cholesterol treatments, essential for millions of patients. Dr. Hannbeck emphasized the economic challenges in the UK medicines market, where low prices have made the country less attractive for some manufacturers, potentially leading to delays in medication availability and price spikes.
In response to these concerns, the Department of Health and Social Care assured that the majority of licensed medicines in the UK are currently well supplied. To enhance the resilience of the medicine supply chain, the department is investing in domestic manufacturing, offering financial incentives for increased production, and implementing strategies to mitigate risks. The government is also collaborating with partner countries to strengthen supply chains and ensure the continuity of healthcare services for patients.
Pharmacies are calling for immediate actions to safeguard the supply of essential medicines, including restrictions on the export and stockpiling of critical medications. As the nation faces potential challenges in medication availability, stakeholders are working to address the issue and ensure the continuous provision of necessary healthcare products.
